ACTA PHARMACEUTICA

期刊基本信息

  • 期刊名称:ACTA PHARMACEUTICA
  • 期刊级别: Science Citation Index Expanded (SCIE) Scopus (CiteScore) Directory of Open Access Journals (DOAJ)
  • 期刊ISSN:1330-0075
  • 期刊EISSN:1846-9558
  • 简称:ACTA PHARMACEUT
  • 影响因子:1.4
  • 实时影响因子:截止2025年5月19日:1.412
  • 五年影响因子:2.4
  • JCI期刊引文指标:0.54
  • h-index:49
  • 2024-2025自引率:0.00%
  • 期刊官方网站:期刊官方网站
  • 期刊投稿网址:Submit By Email: acta.pharmaceutica@farmaceut.org or svjetlana.luterotti@gmail.com or svjetlana.luterotti@pharma.hr
  • 是否OA开放访问:Yes
  • 出版商:Sciendo, a De Gruyter company
  • 出版年份:1951

ACTA PHARMACEUTICA

Science Citation Index Expanded (SCIE)Scopus (CiteScore)Directory of Open Access Journals (DOAJ)

期刊介绍

Acta Pharmaceutica (AP) is an international, scientific, multidisciplinary journal, devoted to the pharmaceutical and allied sciences, which contains articles predominantly on core biomedical and health subjects. The aim of AP is to increase the impact of pharmaceutical research in academia, industry and laboratories. With a strong emphasis on quality and originality, AP publishes reports from the discovery of a drug up to clinical practice, in the form of preliminary and short communications, original research papers and reviews. Book reviews are published also.

AP is a quarterly, single-blind peer-reviewed journal in biomedicine with fully open access and “early bird” platform. All articles are submitted to scrutinized evaluation and fair judgement. AP above all puts scientific honesty and integrity.


To reach the highest standards in publication ethics all the parties (authors, editors, reviewers) are required to behave responsibly and ethically. This implies submittance by authors on an exclusive basis, of only their own and new data; novelty and originality are prioritized. Also, secure handling of confidential data by reviewers and editors is a must.

AP is indexed in numerous world top international bibliographic bases, like Clarivate Analytics´s Web of Science® Core Collection (SCI-Expanded, JCR/Science Edition, etc.), EMBASE/Excerpta Medica, MEDLINE/PubMed, Scopus/SCImago, and others. According to SCImago JR it is a Q2 journal (pharmaceutical sciences) with a steadily increasing Clarivate JIF value reaching 2.8 in 2022.


Topics covered are:
• drug design

• molecular modelling/docking studies

• pharmaceutical chemistry/medicinal chemistry

• drug metabolism

• analytics of drugs

• pharmaceutical technology/formulation studies/nanosystems/cosmetology

• pharmaceutical biotechnology

• pharmaceutics/biopharmacy (including pharmacokinetics) and pharmacodynamics

• drug delivery/disposition and stability

• pharmacognosy and phytopharmacy

• pharmacology (clinical and animal)

• toxicology

• clinical pharmacy

• pharmacovigilance

• pharmaceutical and clinical biochemistry

• pharmaceutical biology with genetics/pharmacogenomics/cell biology

• pharmacoepidemiology/pharmacoeconomics/social pharmacy

• physical pharmacy

• radiopharmaceuticals

• medicine (including diagnostics and therapy)

• peptide and protein chemistry/protein design

投稿要求

  • 通讯方式:HRVATSKO FARMACEUTSKO DRUSTOV (HFD)-CROATION PHARMACEUTICAL SOC, MASARYKOVA 2, ZAGREB, CROATIA, 10000
  • 涉及的研究方向:PHARMACOLOGY & PHARMACY-
  • 出版国家或地区:CROATIA
  • 出版语言:English
  • 年文章数:43
  • PubMed Central (PMC)链接:http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1330-0075%5BISSN%5D

CITESCORE

CiteScoreSJRSNIPCiteScore排名
4.500.3980.607
学科分区排名百分位
大类:Pharmacology, Toxicology and Pharmaceutics
小类:Pharmacology
Q2161 / 321
50%
大类:Pharmacology, Toxicology and Pharmaceutics
小类:Pharmaceutical Science
Q278 / 185
58%

WOS期刊JCR分区

WOS分区等级:4区

按JIF指标学科分区收录子集JIF分区JIF排名JIF百分位
学科:PHARMACOLOGY & PHARMACYSCIEQ4280/352
20.6%
按JCI指标学科分区收录子集JCI分区JCI排名JCI百分位
学科:PHARMACOLOGY & PHARMACYSCIEQ3216/353
38.95%

期刊分区表预警名单

2025年03月发布的2025版:不在预警名单中

2024年02月发布的2024版:不在预警名单中

2023年01月发布的2023版:不在预警名单中

2021年12月发布的2021版:不在预警名单中

2020年12月发布的2020版:不在预警名单中

中科院2025年3月升级版

点击查看中国科学院期刊分区趋势图
大类学科小类学科Top期刊综述期刊
医学 3区4区4区
PHARMACOLOGY & PHARMACY
药学
2区3区4区

中科院2023年12月旧的升级版

大类学科小类学科Top期刊综述期刊
医学 3区4区2区
PHARMACOLOGY & PHARMACY
药学
3区2区4区

联系我们

QQ:1211130760

微信:iqkan555

微信扫码加好友 微信扫码加好友
QQ扫码加好友 QQ扫码加好友